Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol Myers Squibb
Bristol Myers Squibb
Bristol Myers CEO says India to have largest R&D presence outside US by 2025
Reuters
Tue, 02/27/24 - 11:17 am
Bristol Myers Squibb
R&D
India
Bristol Myers Squibb invests over $400m in sterile drug product facility
Biopharma Reporter
Thu, 02/22/24 - 11:38 am
Bristol Myers Squibb
drug manufacturing
Europe
Dublin
Ireland
Novo, Novartis, BMS and J&J win judge's blessing to combine arguments in upcoming IRA hearing
Fierce Pharma
Wed, 02/21/24 - 11:25 am
Novo Nordisk
Novartis
JNJ
Bristol Myers Squibb
legal
Inflation Reduction Act
drug pricing
BMS signs $674M biobucks pact with Roivant's VantAI for molecular glues
Fierce Biotech
Tue, 02/13/24 - 11:31 am
Bristol Myers Squibb
Roivant
VantAI
artificial intelligence
molecular glue
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
BioSpace
Sun, 02/11/24 - 03:50 pm
earnings
COVID-19
GLP-1 agonist
JNJ
Bristol Myers Squibb
Pfizer
AstraZeneca
Sanofi
Eli Lilly
Novo Nordisk
Pharma CEOs, pressed by Senate panel, refuse to commit to price cuts
BioPharma Dive
Fri, 02/9/24 - 11:26 am
Senate
drug pricing
Pharma CEOs
Bristol Myers Squibb
Chris Boerner
JNJ
Joaquin Duato
Merck
Rob Davis
PBMs take bulk of blame as senators question BMS, J&J and Merck CEOs on high drug prices in US
Fierce Pharma
Thu, 02/8/24 - 10:08 pm
Bernie Sanders
drug pricing
Pharma CEOs
Senate
Merck
Bristol Myers Squibb
JNJ
Rob Davis
Chris Boerner
Joaquin Duato
With Merck, J&J and BMS CEOs set to testify, Sanders releases scathing report on drug prices
Fierce Pharma
Tue, 02/6/24 - 11:33 pm
Bernie Sanders
drug pricing
Merck
JNJ
Bristol Myers Squibb
Pharma CEOs
Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data
Xtalks
Mon, 02/5/24 - 10:17 am
oncology
cancer
Keytruda
Revlimid
Opdivo
Imbruvica
Darzalex
Merck
Bristol Myers Squibb
AbbVie
Janssen
FDA sets date for high-profile CAR-T adcomm for Bristol's Abecma, J&J's Carvykti
Fierce Pharma
Sun, 02/4/24 - 12:39 pm
Bristol Myers Squibb
Abecma
FRDA
CAR-T
JNJ
Carvykti
Bristol Myers CEO sees mid-decade transition, late decade growth
Reuters
Sun, 02/4/24 - 12:35 pm
Bristol Myers Squibb
Pharma CEOs
Chris Boerner
BMS more likely to bet on bolt-ons after recent buying spree
Fierce Biotech
Fri, 02/2/24 - 11:59 am
Bristol Myers Squibb
M&A
earnings
Cour gets $105M, pharma help to ‘reprogram’ autoimmune disease
BioPharma Dive
Tue, 01/30/24 - 11:10 am
Cour Pharmaceuticals
funding
autoimmune disease
Roche
Pfizer
Bristol Myers Squibb
nanoparticles
BMS' subcutaneous Opdivo clears first phase 3 trial
Pharmaphorum
Mon, 01/29/24 - 11:06 am
Bristol Myers Squibb
Opdivo
clinical trials
kidney cancer
subcutaneous Opdivo
BMS won out against other pharmas in bid for RayzeBio, just days after competing for Karuna
Fierce Biotech
Thu, 01/25/24 - 09:02 pm
Bristol Myers Squibb
M&A
Rayze Bio
radiopharmaceuticals
Karuna, Cerevel might be just the start of psychiatry drug M&A
BioPharma Dive
Tue, 01/23/24 - 11:17 am
M&A
Karuna Therapeutics
Cerevel Therapeutics
schizophrenia
AbbVie
Bristol Myers Squibb
Two more pharmas practice their Accent, invest in $75M series C round
Fierce Biotech
Tue, 01/23/24 - 10:47 am
Accent Therapeutics
funding
RNA
Bristol Myers Squibb
JNJ
AbbVie
Another big pharma competed for Karuna, submitting all-cash offer day before BMS deal announcement
Fierce Biotech
Mon, 01/22/24 - 10:17 pm
Karuna Therapeutics
Bristol Myers Squibb
M&A
Bristol Myers shows power of Opdivo-Yervoy combo in first-line colorectal cancer subset
Fierce Pharma
Sun, 01/21/24 - 05:09 pm
Bristol Myers Squibb
colorectal cancer
Opdivo-Yervoy
Jilted by Bristol Myers, Ikena cuts headcount by 35% in retreat from drug discovery
Fierce Biotech
Fri, 01/19/24 - 09:28 am
Ikena Oncology
Bristol Myers Squibb
layoffs
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »